Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Willis S. Bowman
Evidence-Based Review of Data on the Combination Inhaler Umeclidinium/Vilanterol in Patients With COPD
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Hexahistidine-Tag-Specific Optical Probes for Analyses of Proteins and Their Interactions
Analytical Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Related publications
Patient Considerations in the Treatment of COPD: Focus on the New Combination Inhaler Umeclidinium/Vilanterol
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Initial Inhaler Choice in COPD: Real-World Evidence
Breathe
Pulmonary
Respiratory Medicine
P275 Comparing Clinically Relevant Improvement With Umeclidinium/Vilanterol and Tiotropium/Olodaterol in Symptomatic Copd: A Randomised Non-Inferiority Crossover Trial
Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial
PLoS ONE
Multidisciplinary
Prs21 - Economic Impact of Delaying Initiation With Multiple Inhaler Maintenance Triple Therapy Treatment in Spanish Copd Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Benefits of a Comprehensive COPD Inhaler Identification Aid
Prescriber
Pharmacology
